BFC
EIDX

Bedel Financial Consulting’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bedel Financial Consulting’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-54
Closed -$3K – 964
2020
Q1 		$3K Buy
+54
New +$3K ﹤0.01% 653